CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- PositionOperating margin is 24%, higher than 95% of its Scientific & Technical Instruments peers (median 8.8%)
- FinancialsAltman Z-Score 10.47: safe zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.40%Below 5Y avg (4.76%)
Annual Rate
TWD 2.50Paid annual
Payout Ratio
56.5%Sustainable
Payback Period
30.2 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.68BTWD334.17M · vs all stocks (USD)
Trailing P/E
21.19xvs Scientific & Technical Instruments peers
Revenue (TTM)
3.28BTWD102.63M · vs all stocks (USD)
Profit Margin
18.65%vs Scientific & Technical Instruments peers
52-Week Change
30.96%vs all stocks
Market Capitalization
10.68BTWD334.17M · vs all stocks (USD)
Enterprise Value
9.89BTWD309.67M · vs all stocks (USD)
Trailing P/E
21.19xvs Scientific & Technical Instruments peers
Forward P/E
27.08xvs Scientific & Technical Instruments peers
PEG Ratio
0.2259xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
3.32xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
3.63xvs Scientific & Technical Instruments peers
Enterprise to Revenue
3.02xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
12.87xvs Scientific & Technical Instruments peers
Gross Margin
56.19%vs Scientific & Technical Instruments peers
Profit Margin
18.65%vs Scientific & Technical Instruments peers
Operating Margin
23.99%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
10.86%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
21.73%vs Scientific & Technical Instruments peers
Revenue (TTM)
3.28BTWD102.63M · vs all stocks (USD)
Revenue per Share (TTM)
22.60TWDUpdated Aug 19, 2026Quarterly Revenue Growth
21.70%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
1.77BTWD55.29M · vs all stocks (USD)
EBITDA (TTM)
733.03MTWD22.95M · vs all stocks (USD)
Net Income (TTM)
611.57MTWD19.14M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
123.80%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
563.72MTWD17.65M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
302.66MTWD9.47M · vs all stocks (USD)
Trailing Annual Dividend Rate
2.50TWDUpdated Aug 19, 2026Trailing Annual Dividend Yield
3.40%vs all stocks
5-Year Average Dividend Yield
4.76%vs all stocks
Payout Ratio
56.49%vs Scientific & Technical Instruments peers
Revenue
2.94BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
1.39BTWDFY2025 · Dec 31, 2025Gross Profit
1.56BTWDFY2025 · Dec 31, 2025Operating Income
529.60MTWD16.58M · vs all stocks (USD)
Pre-tax Income
529.59MTWDFY2025 · Dec 31, 2025Income Tax Expense
105.50MTWDFY2025 · Dec 31, 2025Net Income
424.09MTWDFY2025 · Dec 31, 2025EBIT
531.47MTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
618.72MTWDFY2025 · Dec 31, 2025Research & Development
274.15MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
754.08MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.88MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
441.08MTWDFY2025 · Dec 31, 2025Free Cash Flow
350.82MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
498.61MTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
529.59MTWDFY2025 · Dec 31, 2025Other Non-cash Items
-3.71MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
29.19MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-113.98MTWDFY2025 · Dec 31, 2025Capital Expenditures
-90.27MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.16MTWDFY2025 · Dec 31, 2025Purchase of Investments
-104.70MTWDFY2025 · Dec 31, 2025Sale of Investments
13.06MTWDFY2025 · Dec 31, 2025Other Investing Activity
19.05MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-162.86MTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-221.29MTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
15.17MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-290.10MTWDFY2025 · Dec 31, 2025Other Financing Charges
248.00KTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-495.96MTWDFY2025 · Dec 31, 2025Shares Outstanding
145.05MSharesUpdated Aug 19, 2026Float Shares
60.61MSharesUpdated Aug 19, 2026% Held by Insiders
60.64%vs all stocks
% Held by Institutions
1.19%vs all stocks
Total Cash (MRQ)
929.42MTWD29.09M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.42TWDUpdated Aug 19, 2026Total Debt (MRQ)
31.39MTWD982.48K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0105xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
2.51xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
20.67TWDUpdated Aug 19, 2026Total Assets
3.74BTWD117.01M · vs all stocks (USD)
Total Current Assets
2.42BTWDFY2025 · Dec 31, 2025Total Liabilities
774.30MTWDFY2025 · Dec 31, 2025Total Non-current Assets
1.32BTWDFY2025 · Dec 31, 2025Total Non-current Liabilities
121.12MTWDFY2025 · Dec 31, 2025Total Current Liabilities
653.18MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents
498.61MTWDFY2025 · Dec 31, 2025Other Short-term Investments
82.82MTWDFY2025 · Dec 31, 2025Accounts Receivable
673.88MTWDFY2025 · Dec 31, 2025Inventory
1.00BTWDFY2025 · Dec 31, 2025Accounts Payable
188.01MTWDFY2025 · Dec 31, 2025Short-term Debt
56.79MTWDFY2025 · Dec 31, 2025Other Current Liabilities
13.10MTWDFY2025 · Dec 31, 2025Long-term Debt
9.85MTWDFY2025 · Dec 31, 2025Other Non-current Liabilities
13.46MTWDFY2025 · Dec 31, 2025Common Stock (Book)
1.45BTWDFY2025 · Dec 31, 2025Retained Earnings
985.42MTWDFY2025 · Dec 31, 2025Total Shareholders' Equity
2.96BTWD92.77M · vs all stocks (USD)
52-Week Low
44.65TWDUpdated Aug 19, 202652-Week High
87.90TWDUpdated Aug 19, 202652-Week Change
30.96%vs all stocks
50-Day MA
75.36TWDUpdated Aug 19, 2026200-Day MA
60.26TWDUpdated Aug 19, 2026Avg 10-Day Volume
167.62KSharesUpdated Aug 19, 2026Avg 30-Day Volume
252.95KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
3.54TWDUpdated Aug 19, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Three-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Three years of positive free cash flow, with the 50-week average above the 200-week.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 24%, higher than 95% of its Scientific & Technical Instruments peers (median 8.8%)Significant
Operating margin: 0.24Industry median: 0.09Industry P95: 0.23Peers compared: 64.00
Return on equity is 21.7%, higher than 95% of its Scientific & Technical Instruments peers (median 4.8%)Significant
Return on equity: 0.22Industry median: 0.05Industry P95: 0.20Peers compared: 64.00
Financial Health
Altman Z-Score 10.47: safe zoneNotable
Altman Z-Score: 10.47
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Rokit Healthcare Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Enchem Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangxi Hechi Chemical Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Double Arrow Rubber Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
PlayNitride Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Neosem Inc.
Tier 1ProductionThroughput-Bound ConversionInterfaceSenseMaking
Liuzhou Chemical Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Harbin Viti Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wuxi Xinan Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Dayang Biotech Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Catalyst Pharmaceuticals Inc.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMAThree Asset-Base Ratios Elevated
Thyrocare Technologies Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMAThree Asset-Base Ratios Elevated
Garmin Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated